Semaglutide before catheter ablation for atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether taking semaglutide (a weight-loss medication) before a catheter ablation procedure helps improve outcomes for people with atrial fibrillation and excess weight. If you qualify, it might help reduce the chance of the abnormal heart rhythm coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have symptomatic atrial fibrillation and are scheduled for your first catheter ablation.
- Your BMI is 30 or higher, or 28 or higher with a weight-related health issue.
- You have not taken GLP-1 medications (like semaglutide) before.
- You do not have diabetes, and have not had weight-loss surgery.
- You have not had major heart or stroke events recently, and no active cancer or uncontrolled thyroid disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a weight loss medication (semaglutide) given before and after a first-time heart ablation procedure for atrial fibrillation can improve outcomes. It is for people who are overweight or obese and have certain related health conditions.
This study looks at whether losing weight can help reduce the progression of atrial fibrillation (an irregular heartbeat). It might help people who are overweight and have AF symptoms.
This study tests whether a weekly injection of semaglutide (the same drug in Wegovy and Ozempic) can help people with atrial fibrillation lose weight and improve their heart condition. It's for people with AF who also have obesity, and may or may not plan to have a heart procedure called catheter ablation.
This study tests whether taking semaglutide (a once-weekly injection that helps control appetite and blood sugar) before and after a second weight-loss surgery can help people who regained weight after an initial sleeve gastrectomy. The goal is to see if the medicine improves weight-loss outcomes compared to surgery alone.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This trial tests whether taking a weekly injection called semaglutide (a type of medicine used for weight loss) for about 16 weeks before weight-loss surgery can help people with a very high BMI prepare for surgery. It may reduce liver fat and make surgery safer, which could lead to better outcomes.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.